Evidence map›Paper›PMID 42163784›Full record

ArticleJournal of applied clinical medical physics2026

Evaluation of the reliability of markerless tumor tracking with single-energy and dual-energy imaging using machine learning.

Ha Nguyen, Jason Luce, Liangjia Zhu, Mathias Lehmann, Hyejoo Kang, Matthew M Harkenrider, John C Roeske

Abstract readEvaluation Study
In one paragraph

Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ha NguyenDepartment of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA.ORCID https://orcid.org/0009-0009-5246-6236
Jason LuceDepartment of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA.
Liangjia ZhuVarian Medical System, Palo Alto, California, USA.
Mathias LehmannVarian Medical System, Palo Alto, California, USA.
Hyejoo KangDepartment of Radiation Oncology, Stritch School of Medicine, Cardinal Bernadin Cancer Center, Loyola University Chicago, Maywood, Illinois, USA.ORCID https://orcid.org/0000-0002-4433-0939
Matthew M HarkenriderDepartment of Radiation Oncology, Loyola University Medical School, Maywood, Illinois, USA.
John C RoeskeDepartment of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA.

Funding

Markerless Motion Tracking of Lung Tumors Using Dual Energy ImagingR01CA207483 · NCI · LOYOLA UNIVERSITY CHICAGO · PI LEHMANN, MATHIAS, ROESKE, JOHN · 2017 to 2025
$2.2M
National Cancer Institute of the National Institutes of Health R01-CA207483NCI NIH HHS R01 CA207483
6 · The paper itself

Abstract

backgroundMarkerless tumor tracking (MTT) using single-energy (SE) kilovoltage (kV) imaging has been proposed as a technique for lung tumor motion management. However, bony structures can obscure the tumor and make tracking challenging. Dual-energy (DE) subtraction imaging can suppress the bone and therefore enhance tumor visibility, potentially improving tracking accuracy. PURPOSE: To develop a machine learning model that predicts the reliability of MTT for SE and DE imaging using phantom and patient data.

methodsImages were collected at high and low energy (120/60 kV) using fast-kV switching on dynamic thorax phantom with 5-15 diameter targets and 20 lung cancer patients, including one patient with two tumor locations. DE images were then generated off-line using weighted logarithmic subtraction. Separately, a template-based tracking algorithm was used to track the tumor on both phantom and patient images. For phantom data, the ground truth (GT) was defined by the cos

resultsFor both SE-LR and DE-LR models, PSR has the largest coefficient value, indicating that it is the most influential factor when determining the reliability of tracking. At a specificity of 95%, the DE-LR model achieved significantly higher sensitivity than the SE-LR model (0.908 vs. 0.731, p < 0.01 for phantom data and 0.657 vs. 0.589, p < 0.01 for patient data). In the three held-out patients, the DE-LR model outperformed the SE-LR model across all metrics. The largest gains were found in the patient with good tracking quality.

conclusionsThe proposed LR models successfully predicted the reliability of SE- and DE-MTT. Across phantom and patient datasets, the DE-LR model consistently demonstrated improved performance compared with the SE-LR model, suggesting that DE imaging may be beneficial for MTT applications.

Indexed as

AlgorithmsImage Processing, Computer-AssistedLung NeoplasmsMachine LearningPhantoms, ImagingRadiography, Dual-Energy Scanned ProjectionRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedHumansRadiotherapy, Intensity-ModulatedReproducibility of Resultsimage‐guided radiation therapymachine learningradiationtumor motion tracking

Identifiers

PMID42163784
PMCPMC13239570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.